Oxford, Serum Institute of India: New Anti-Malaria vaccine trial over, authorization next year 0 08.12.2022 10:49 Economictimes.indiatimes.com The phase 3 trial of the R21 malaria vaccine, also known as Matrix-M and developed by the Jenner Institute at the University of Oxford, has been completed. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
